KIM, Jung Ah

Position : Professor, Division of Hematology-Oncology, Department of Internal Medicine

Specialty :

  • Lung cancer
  • Head and Neck cancer
  • Breast cancer
  • Sarcoma
  • Malignant melanoma

Education :

  • Ewha Women University, College of Medicine, Seoul, Korea (Medical doctor)
  • Ewha Women University College of Medicine, Department of Internal Medicine (Master’s degree)
  • Inje University, School of Medicine (Ph D)

Experience :

  • Clinical Fellow, Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunwan University
  • Clinical Fellow, Inje University Seoul Paik Hospital
  • Clinical Assistant Professor, Division of Hematology-Oncology, Inje University Seoul Paik Hospital
  • Professor, Division of Hematology-Oncology, Kyung Hee University Hospital at Gangdong

Research papers/ Book chapters:

  • Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients Hye In Woo‡,1, Jung A Kim‡,2, Hyun Ae Jung3, Ka-Kyung Kim et al. Pharmacogenomics March 2015 ,Vol. 16, No. 4, Pages 383-391
  • Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer. Cancer chemotherapy pharma -cology 2011 Jul; 68(1):177?-184
  • Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis? Leukemia and lymphoma 2011 Feb;52(2):205-13.
  • A study on effect of LV5FU2 after radical gastrectomy in patients with gastric cancer Chung-Ang J Med 2009;34(3):37-43
  • Clinical presentation of carcinoma of unknown primary: 14 years of experience Tumor Biol 2011;32:45-51
  • Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value? Leuk Lymphoma. 2012;53(1):173-175